Does adding single nucleotide polymorphisms to risk algorithms improve cardiovascular disease risk prediction in rheumatoid arthritis? An internal and external validation of a clinical risk score.

Several SNPs were associated with CVD in RA. Risk prediction slightly improved after adding SNPs to the models, but the clinical relevance is debatable. However, larger studies are needed to determine more accurately the additional value of these SNPs to CVD risk prediction algorithms.